Z-0028-2018 Class II Terminated

Recalled by Cepheid — Sunnyvale, CA

FDA device recall Z-0028-2018 was initiated by Cepheid on Sep 15, 2017 and is designated Class II. Reason for recall: Customers have reported a higher than expected number of invalid test results when using the recalled product per the package insert. The recall status is terminated (terminated Jul 28, 2023). Affected quantity: 977 kits (9770 units).

Recall details

Product Type
Devices
Report Date
Oct 25, 2017
Initiation Date
Sep 15, 2017
Termination Date
Jul 28, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
977 kits (9770 units)

Product description

Xpert EV Assay, Catalog GXEV-100N-10. The Cepheid Xpert EV assay is a reverse transcription polymerase chain reaction (RT-PCR) using the GeneXpert Dx System for the presumptive qualitative detection of enterovirus (EV) RNA in cerebrospinal fluid (CSF) specimens from individuals with signs and symptoms of meningitis.

Reason for recall

Customers have reported a higher than expected number of invalid test results when using the recalled product per the package insert.

Distribution pattern

USA, Austria, Australia, Belgium, Brazil, Canada, Chile, Colombia, Germany, Spain, France, UK, Ireland, Israel, Italy, South Korea, Lebanon, Netherlands, Philippines, Saudi Arabia, Sweden, Uruguay

Code information

batch 1000045409 (lot 06802)

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0028-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0028-2018. Report a data issue: hello@regdatalab.com.